Impella Recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock
Record ID 32013000578
English
Authors' recommendations:
Approximately 6% to 15% of patients with acute myocardial infarction (AMI) present with or develop cardiogenic shock (CS) mainly due to left ventricular (LV) dysfunction. Patients with AMI and CS have a high mortality rate of 40% even with early revascularization. Patients who present with AMI are treated initially with pharmacologic agents (diuretics and inotropes), receive supplemental oxygen or ventilatory support, and are prepared for rapid revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Intra-aortic balloon counterpulsation (IABP) is the standard of care for hemodynamic support for patients with CS.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=15060
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Cardiac Output, Low
- Cardiac Surgical Procedures
- Prosthesis Design
- Shock, Cardiogenic
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2013 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.